Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)

SHE:002412 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Cash & Equivalents	111.58	249.65	128.02	51.13	145.41	90.31
Trading Asset Securities	399.29	333.8	244.12	203.87	135.82	49.24
Cash & Short-Term Investments	510.87	583.45	372.14	255	281.23	139.55
Cash Growth	5.33%	56.78%	45.94%	-9.33%	101.52%	34.75%
Accounts Receivable	401.82	426.42	425.03	352.52	320.57	272.88
Other Receivables	7.93	0.94	0.88	0.63	11.96	1.86
Receivables	409.74	437.17	442	359.99	332.53	274.74
Inventory	214.17	208.44	222.88	231.12	246.62	103.37
Prepaid Expenses	-	9.13	6.9	3.8	-	1.23
Other Current Assets	93.84	83.62	79.25	46.16	5.03	16.51
Total Current Assets	1,229	1,322	1,123	896.07	865.4	535.41
Property, Plant & Equipment	440.38	455.72	489.16	515.61	439.45	470.75
Long-Term Investments	750.02	836.44	855.75	841.81	781.35	707.95
Goodwill	14.73	14.73	14.79	14.79	14.79	53.03
Other Intangible Assets	28.17	28.66	29.3	29.54	33.72	42.58
Long-Term Deferred Tax Assets	1.94	2.24	2.42	2.5	2.04	2.11
Long-Term Deferred Charges	14.31	14.94	14.41	15.13	15.71	16.42
Other Long-Term Assets	15.94	18.52	18.23	21.04	138.47	283.03
Total Assets	2,494	2,693	2,547	2,336	2,291	2,111

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Accounts Payable	22.05	34.28	41.62	41.11	43.63	51.44
Accrued Expenses	17.17	49.97	48.31	62.58	66.83	48.31
Short-Term Debt	2.41	57.5	84.51	95.12	120.15	131.79
Current Income Taxes Payable	10.27	9.04	6.23	11.64	4.61	4.52
Current Unearned Revenue	0.4	0.81	2.72	6.48	7.02	1.71
Other Current Liabilities	27.44	136.72	134.93	138.51	138	113.33
Total Current Liabilities	79.73	288.33	318.32	355.42	380.24	351.11
Long-Term Unearned Revenue	21.7	23.01	24.54	16.81	15.03	16.22
Long-Term Deferred Tax Liabilities	0.83	0.81	1	1.22	1.54	1.66
Total Liabilities	102.26	312.15	343.85	373.46	396.81	368.99

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Common Stock	503.2	503.2	503.2	503.2	503.2	503.2
Additional Paid-In Capital	234.12	234.12	234.12	234.12	234.12	232.77
Retained Earnings	1,639	1,634	1,436	1,215	1,161	993.7
Comprehensive Income & Other	15.46	9.87	30.45	10.34	-4.5	12.63
Total Common Equity	2,392	2,381	2,203	1,963	1,894	1,742
Shareholders' Equity	2,392	2,381	2,203	1,963	1,894	1,742
Total Liabilities & Equity	2,494	2,693	2,547	2,336	2,291	2,111

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Total Debt	2.41	57.5	84.51	95.12	120.15	131.79
Net Cash (Debt)	508.46	525.95	287.63	159.88	161.08	7.76
Net Cash Growth	18.25%	82.86%	79.90%	-0.74%	1975.89%	-
Net Cash Per Share	1.01	1.05	0.57	0.32	0.32	0.02
Filing Date Shares Outstanding	503.2	503.2	503.2	503.2	503.2	503.2
Total Common Shares Outstanding	503.2	503.2	503.2	503.2	503.2	503.2
Working Capital	1,149	1,033	804.85	540.65	485.17	184.3
Book Value Per Share	4.75	4.73	4.38	3.90	3.76	3.46
Tangible Book Value	2,349	2,338	2,159	1,919	1,846	1,647
Tangible Book Value Per Share	4.67	4.65	4.29	3.81	3.67	3.27
Buildings	-	648.15	647.47	644.48	531.89	533.67
Machinery	-	231.59	228.7	223.66	221.69	218.69
Construction In Progress	-	12.77	10.8	9.08	6.09	5.26

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error